A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Clinical trial NCT07017777 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07017777
Sponsor: CanSino Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infections Streptococcal Infections Bacterial Infections

Start date: 2025-11-14
Primary completion: 2027-02-15
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.